First Financial Equity Corporation’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

First Financial Equity Corporation’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$3.35M	Buy	+48,083	New	+$3.23M	0.57%	56

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

First Financial Equity Corporation's XBI Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2017: 48,083 shares worth $3.35M. The stake represents 0.57% of the portfolio and ranks #56 among its holdings.

292 funds tracked by Wall St. Rank hold XBI as of Q1 2017.

First Financial Equity Corporation held 48,083 shares of State Street SPDR S&P Biotech ETF worth $3.35M as of Q1 2017.
State Street SPDR S&P Biotech ETF was a new First Financial Equity Corporation position in Q1 2017.
State Street SPDR S&P Biotech ETF made up 0.57% of First Financial Equity Corporation's portfolio in Q1 2017, its #56 holding.
292 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.